You’re invited to join corporate partners of Children’s Cancer Research Fund for an exclusive afternoon of recognition and discovery.
On behalf of Children’s Cancer Research Fund, CEO Elizabeth Allen is honored to welcome you to the 2025 Partners for Progress.
Thursday, October 2, 2025
4:00 – 6:00 p.m.
Riva Terrace at The Four Seasons
245 Hennepin Ave,
Minneapolis, MN 55401
At Partners for Progress, we’ll celebrate the impact of our corporate partners and share a glimpse into the future of childhood cancer research. Together, we’ll reflect on all we’ve accomplished and look ahead to the bold discoveries that your partnership makes possible.
Program Highlights
Begin the afternoon with cocktails and hors d’oeuvres while connecting with fellow leaders who share your commitment to accelerating childhood cancer research.
Expert Panel: The Future of Childhood Cancer Research
Hear from distinguished researchers Dr. Lucie Turcotte of the University of Minnesota and Dr. Anne Bendel of Children's Minnesota, as they share insights into emerging treatments and the opportunities on the horizon. This conversation, guided by CCRF CEO Elizabeth Allen, offers a closer look at discoveries shaping the future of care for children with cancer.
Close the evening by continuing the conversation with your peers. As a token of our gratitude, guests will receive a special gift from CCRF partner, Kendra Scott.
Featuring
Inspired by the opportunity to improve the lives of children with cancer, Elizabeth often says that CCRF is turning heartbreak into hope. As CEO, she has shown a tireless commitment to growing the CCRF community of supporters, fueling research progress, and ensuring that bold discoveries reach the kids who need them most.
Dr. Turcotte is a pediatric hematologist/oncologist at the University of Minnesota, where she serves as Division Director of Pediatric Hematology/Oncology and Director of the Survivorship Program. She specializes in pediatric blood disorders and cancers, with a focus on childhood leukemias, lymphomas, and histiocytic disorders. Her research centers on survivorship, studying how cancer therapies impact children and adolescents long-term, with the goal of advancing safer, more effective treatments.
Dr. Bendel is a pediatric hematologist/oncologist at Children’s Minnesota, where she serves as Director of the Neuro-Oncology Program and holds the Harper Family Foundation Endowed Chair for Cancer Research and Novel Therapies. She has dedicated her nearly 30-year career at Children’s to caring for children and young adults with central nervous system (CNS) tumors. With a deep commitment to both patient care and research, Dr. Bendel collaborates across multiple specialties and leads clinical studies to advance safer, more effective treatments. She is also an active member of national and international research groups, ensuring her patients have access to cutting-edge therapies.